Secondary antibodies used were goat anti-mouse DyLight 549, goat anti-rat DyLight 549, and goat anti-rabbit DyLight 488, 1:200 (Agrisera)
GHK-Cu Nasal Spray peptide FAQ Q1: What is GHK-Cu in a research context
BPC-157 also restores glutamatergic signaling after NMDA receptor overactivation (e.g., ketamine, MK-801 exposure) and modulates adrenergic balance by counteracting beta-adrenergic overstimulation and blockade, preventing vascular occlusion-like syndromes
This is the same mechanism behind Wegovy, Ozempic, and the Wegovy pill
These studies are less valuable than human studies, as we cannot assume that BPC-157 will behave in humans exactly as it does in animals
Infographic Brief 3 Placement: After ## Side Effects and Safety Concerns Title: GHK-Cu Safety Considerations by Route Purpose: Show how safety questions differ between topical GHK-Cu, wound-care formulations, and injectable or compounded preparations